Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,382,803	$ 439,272
Trade accounts receivable, less allowance for doubtful accounts (2022 – $2,495; 2021 – $2,559)	1,035,117	556,922
Other accounts receivable	135,709	66,184
Inventories	1,614,299	798,620
Other current assets	129,043	132,683
Total current assets	4,296,971	1,993,681
Property, plant and equipment, at cost	8,713,771	8,074,746
Less accumulated depreciation and amortization	2,288,664	2,165,130
Net property, plant and equipment	6,425,107	5,909,616
Investments	1,158,535	912,008
Other assets	217,057	252,239
Goodwill	1,467,848	1,597,627
Other intangibles, net of amortization	262,984	308,947
Total assets	13,828,502	10,974,118
Current liabilities:
Accounts payable	1,651,866	647,986
Accrued expenses	385,327	763,293
Current portion of long-term debt	251,216	389,920
Dividends payable	46,098	45,469
Income taxes payable	153,444	27,667
Total current liabilities	2,487,951	1,874,335
Long-term debt	3,118,753	2,004,319
Postretirement benefits	42,681	43,693
Pension benefits	187,498	229,187
Other noncurrent liabilities	597,980	663,698
Deferred income taxes	429,012	353,279
Commitments and contingencies (Note 10)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 117,145 in 2022 and 117,015 in 2021	1,171	1,170
Additional paid-in capital	2,933,659	2,920,007
Accumulated other comprehensive loss	(717,309)	(392,450)
Retained earnings	4,515,115	3,096,539
Total Albemarle Corporation shareholders’ equity	6,732,636	5,625,266
Noncontrolling interests	231,991	180,341
Total equity	6,964,627	5,805,607
Total liabilities and equity	$ 13,828,502	$ 10,974,118